Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Crism Thera (CRTX) Share Price

Price 12.00p on 04-12-2025 at 10:10:07
Change 0.00p 0%
Buy 13.00p
Sell 11.00p
Last Trade: Buy 230.00 at 13.00p
Day's Volume: 277
Last Close: 12.00p
Open: 12.00p
ISIN: VGG042401262
Day's Range 12.00p - 12.00p
52wk Range: 6.25p - 29.00p
Market Capitalisation: £4.80m
VWAP: 12.66065p
Shares in Issue: 39.96m

Crism Thera (CRTX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 230 13.00p Ordinary
08:33:11 - 04-Dec-25
Sell* 47 11.00p Ordinary
08:31:07 - 04-Dec-25
Sell* 2,500 11.70p Ordinary
12:12:16 - 03-Dec-25
Sell* 50 11.00p Ordinary
10:23:44 - 03-Dec-25
Sell* 625 11.00p Ordinary
08:03:20 - 03-Dec-25
Sell* 625 11.00p Ordinary
15:01:58 - 02-Dec-25
Sell* 3,000 11.26p Ordinary
12:09:10 - 02-Dec-25
Unknown* 841 11.00p OTC Trade
10:50:00 - 02-Dec-25
Sell* 841 11.00p Ordinary
10:49:59 - 02-Dec-25
Sell* 206 11.00p Ordinary
14:27:29 - 01-Dec-25
See more Crism Thera trades

Crism Thera (CRTX) Share Price History

Time period:
to
Date Open High Low Close Volume
4th Dec 2025 (Thu) 12.00 12.00 12.00 12.00 277
3rd Dec 2025 (Wed) 12.00 12.00 12.00 12.00 3,175
2nd Dec 2025 (Tue) 12.00 12.00 12.00 12.00 5,307
1st Dec 2025 (Mon) 12.00 12.00 12.00 12.00 206
28th Nov 2025 (Fri) 12.00 12.00 12.00 12.00 45,636
27th Nov 2025 (Thu) 12.00 12.00 12.00 12.00 26,198
26th Nov 2025 (Wed) 12.00 12.00 12.00 12.00 70,974
25th Nov 2025 (Tue) 12.00 12.00 12.00 12.00 14,978
24th Nov 2025 (Mon) 12.00 12.00 12.00 12.00 10,266
21st Nov 2025 (Fri) 13.00 13.00 12.00 12.00 165,605
20th Nov 2025 (Thu) 13.50 13.50 13.00 13.00 92,054
19th Nov 2025 (Wed) 12.00 14.00 12.00 13.50 543,096
18th Nov 2025 (Tue) 12.00 12.00 12.00 12.00 67,506
17th Nov 2025 (Mon) 12.00 12.00 12.00 12.00 13,474
14th Nov 2025 (Fri) 12.00 12.00 12.00 12.00 28,927
13th Nov 2025 (Thu) 12.00 12.00 12.00 12.00 10,607
12th Nov 2025 (Wed) 12.00 12.00 12.00 12.00 12,307
11th Nov 2025 (Tue) 12.00 12.00 12.00 12.00 9,264
10th Nov 2025 (Mon) 12.00 12.00 12.00 12.00 51,313
7th Nov 2025 (Fri) 12.00 12.00 12.00 12.00 100,481
6th Nov 2025 (Thu) 12.00 12.00 12.00 12.00 7,267
5th Nov 2025 (Wed) 12.00 12.00 12.00 12.00 1,624
4th Nov 2025 (Tue) 12.00 12.00 12.00 12.00 72,032
See more Crism Thera price history

Crism Thera (CRTX) Regulatory News

Date Source Headline
27th Nov 2025 7:00 am RNS Holding(s) in Company
30th Oct 2025 7:00 am RNS US Orphan Drug Designation Application
14th Oct 2025 7:00 am RNS Positive Preclinical Data in Prostate Cancer
15th Sep 2025 7:00 am RNS Half Year Report
12th Sep 2025 7:00 am RNS Notice of Interim Results and IMC Presentation
1st Sep 2025 7:00 am RNS Approval for phase 2 clinical trial
26th Aug 2025 4:03 pm RNS Result of AGM
26th Aug 2025 7:00 am RNS AGM Statement
12th Aug 2025 7:00 am RNS GMP Manufacture of ChemoSeed
4th Aug 2025 5:45 pm RNS Notice of AGM and EMI Option Plan
See more Crism Thera regulatory news

Crism Thera (CRTX) Share News

CRISM reports "significant" preclinical data for prostate cancer drug

14th Oct 2025 16:50

(Alliance News) - CRISM Therapeutics Corp said on Tuesday that preclinical studies show that its ChemoSeed drug delivery platform could "could substantially enhance" the efficacy of docetaxel in the treatment of prostate cancer. Read More

EARNINGS: CRISM loss widens as "actively" prepares for phase 2 trial

15th Sep 2025 21:41

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: CRISM confident in ChemoSeed as targets trial approval

26th Aug 2025 13:56

CRISM Therapeutics Corp - British Virgin Islands-based pharmaceutical firm - As the firm held its annual general meeting, Chair Nermeen Varawalla says the firm must attract, retain and incentivise the best people as it continues to seek further validation for its novel delivery method. "[We] are confident that ChemoSeed has the potential to transform treatment for patients with solid-tumour cancers," Chair Varawalla continues. ChemoSeed is an implantable biodegradable drug delivery technology designed for the sustained delivery of chemotherapy directly into cancer tissue. Chair Varawalla says the company is focused on gaining trial approval from the UK Medicines & Healthcare products Regulatory Agency in glioblastoma and progressing towards dosing first patients in early 2026. Read More

UK shareholder meetings calendar - next 7 days

19th Aug 2025 14:58

Read More

LONDON MARKET MIDDAY: London mixed as mortgage data beats expectations

30th Jun 2025 12:01

(Alliance News) - London stocks were mixed at midday on Monday, as US tariff uncertainty continues to weigh on investor sentiment despite a data reading confirming UK economic growth at the start of the year. Read More

See more Crism Thera news
FTSE 100 Latest
Value9,691.72
Change-0.35

Login to your account

Forgot Password?

Not Registered